NeuroMetrix Inc (NURO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:NeuroMetrix Inc (NURO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6365
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NeuroMetrix Inc (NeuroMetrix) is a healthcare company company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, quell health cloud, DPNCheck point-of-care neuropathy test and advance system. Its DPNCheck is used for the treatment of diabetic peripheral neuropathy. NeuroMetrix offers services in basic and clinical neurophysiology, biomedical engineering and instrumentation, and information technology. The company serves clinics, hospitals, managed care organizations, retail health businesses, and durable medical equipment suppliers. It markets its products through its network of distributors in Americas, Europe, Asia, and the Middle East. NeuroMetrix is headquartered in Waltham, Massachusetts, the US.

NeuroMetrix Inc (NURO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NeuroMetrix Inc, Medical Equipment, Deal Details 11
Partnerships 11
NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare 11
NeuroMetrix Enters into Agreement with Fukuda Denshi 12
NeuroMetrix Enters into Agreement with Synovation Medical 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 17
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 18
Equity Offering 19
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 19
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 21
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 22
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 24
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 27
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 29
NeuroMetrix Raises USD8 Million in Private Placement of Securities 31
NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million 32
NeuroMetrix Completes Public Offering Of Units For US$8.5 Million 33
Asset Transactions 34
GSK Consumer Healthcare to Acquire Quell technology from NeuroMetrix 34
NeuroMetrix Inc – Key Competitors 35
NeuroMetrix Inc – Key Employees 36
NeuroMetrix Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Joint Venture 37
Recent Developments 38
Financial Announcements 38
Jul 20, 2018: NeuroMetrix reports Q2 2018 financial results 38
Jan 25, 2018: NeuroMetrix Reports Q4 and Full Year 2017 Financial Results 39
Jan 08, 2018: NeuroMetrix Reports Preliminary 2017 Financial Highlights 40
Oct 19, 2017: NeuroMetrix Reports Q3 2017 Financial Results 41
Jul 20, 2017: NeuroMetrix Reports Q2 2017 Financial Results 42
Apr 20, 2017: NeuroMetrix Reports Q1 2017 Financial Results 43
Jan 26, 2017: NeuroMetrix Reports Q4 and Full Year 2016 Financial Results 44
Jan 10, 2017: NeuroMetrix Reports Strong Quell Demand in Q4 2016 45
Corporate Communications 46
Jul 06, 2017: NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics 46
Product News 47
Aug 28, 2018: NeuroMetrix reports presentation of clinical and scientific data on Quell Wearable Pain Relief Technology at PAINWeek 2018 National Conference 47
Apr 24, 2018: NeuroMetrix to Present Quell Data at Upcoming American Academy of Pain Medicine Annual Meeting 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
NeuroMetrix Inc, Medical Equipment, Key Facts, 2017 2
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeuroMetrix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeuroMetrix Inc, Deals By Market, 2012 to YTD 2018 9
NeuroMetrix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare 11
NeuroMetrix Enters into Agreement with Fukuda Denshi 12
NeuroMetrix Enters into Agreement with Synovation Medical 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
NeuroMetrix Enters Into Distribution Agreement With DJO Global For Sensus Pain Management System 15
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 16
NeuroMetrix Enters Into Distribution Agreement With Omron Healthcare For NC-stat DPNCheck 17
NeuroMetrix Enters Into Distribution Agreement With Handok Pharma For NC-stat DPNCheck 18
NeuroMetrix Raises USD3.5 Million in Private Placement of First Tranche of Series F Preferred Stock 19
NeuroMetrix Plans to Raise Funds through Public Offering of Shares 21
NeuroMetrix Raises USD4 Million in Private Placement of Series E Preferred Stock and Warrants 22
NeuroMetrix Prices Public Offering of Shares for USD26.5 Million 24
NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants 26
NeuroMetrix Raises USD13.8 Million in Private Placement of Shares and Warrants 27
NeuroMetrix Raises USD14.7 Million in Public Offering of Units 29
NeuroMetrix Raises USD8 Million in Private Placement of Securities 31
NeuroMetrix Completes Private Placement Of Preferred Shares For US$5 Million 32
NeuroMetrix Completes Public Offering Of Units For US$8.5 Million 33
GSK Consumer Healthcare to Acquire Quell technology from NeuroMetrix 34
NeuroMetrix Inc, Key Competitors 35
NeuroMetrix Inc, Key Employees 36
NeuroMetrix Inc, Joint Venture 37

List of Figures
NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NeuroMetrix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
NeuroMetrix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
NeuroMetrix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
NeuroMetrix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[NeuroMetrix Inc (NURO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electricite de France SA (EDF):企業の財務・戦略的SWOT分析
    Electricite de France SA (EDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Loews Corporation:戦略・SWOT・企業財務分析
    Loews Corporation - Strategy, SWOT and Corporate Finance Report Summary Loews Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Top Image Systems Ltd. (TISA):企業の財務・戦略的SWOT分析
    Top Image Systems Ltd. (TISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Oil and Natural Gas Corporation Limited:企業の戦略・SWOT・財務情報
    Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Oil and Natural Gas Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Neviot Nature of Galilee Ltd.:企業の戦略・SWOT・財務分析
    Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report Summary Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Power Machines-エネルギー分野:企業M&A・提携分析
    Summary Power Machines is a power engineering company that designs, manufactures and delivers equipment for thermal, nuclear, hydraulic and gas turbine power plants. The company offers steam, gas and hydraulic turbines, turbo-generators, hydraulic generators, blades for steam and gas turbines and ex …
  • BNP Paribas SA:企業の戦略・SWOT・財務情報
    BNP Paribas SA - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PanAust Ltd:企業の戦略・SWOT・財務情報
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • BioPorto AS (BIOPOR):企業の財務・戦略的SWOT分析
    BioPorto AS (BIOPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kenya Electricity Generating Co Ltd:発電所・企業SWOT分析
    Kenya Electricity Generating Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Jordan International Insurance Company (JIJC):企業の財務・戦略的SWOT分析
    Jordan International Insurance Company (JIJC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and ga …
  • Genocea Biosciences Inc (GNCA):企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc is a biopharmaceutical company develops targeted vaccines and immunotherapies for the treatment of cancer. The company’s pipeline products include Gen-009 and Gen-010, a neoantigen cancer vaccine; Gen-011 is an adoptive T cell therapy. …
  • Dexcel PT Israel Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd, develops, manufactures and markets branded and generic pharmaceuticals. Its featured products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planing and adult p …
  • Blue Dolphin Energy Company (BDCO):石油・ガス:M&Aディール及び事業提携情報
    Summary Blue Dolphin Energy Company (Blue Dolphin) is an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolphin o …
  • Precipio Inc (TBIO):企業の財務・戦略的SWOT分析
    Summary Precipio Inc (Precipio), formerly known as Transgenomic Inc, develops diagnostic tools. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. Precipio uses ICE COLD-P …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Xerox Corporation:企業の戦略・SWOT・財務情報
    Xerox Corporation - Strategy, SWOT and Corporate Finance Report Summary Xerox Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nanoco Group Plc (NANO):企業の財務・戦略的SWOT分析
    Nanoco Group Plc (NANO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆